Bristol-Myers Squibb Company PFD CONV 2

Bristol-Myers Squibb is a pharmaceutical company dedicated to the research, development, and commercialization of treatments for a wide array of medical conditions. Its primary therapeutic domains include cardiovascular health, oncology, and immunological disorders. A significant strategic emphasis for the firm is immuno-oncology, an area where it has established itself as a leading innovator in developing new drugs. The company generates approximately 70% of its total revenue from the United States, indicating a considerably higher reliance on the American market compared to many of its industry counterparts.